Working with King's College Hospital

Blood disorders and cancers affect thousands of adults every year in the UK. At King's the haematology team are busy developing new life saving and life improving treatments. With our support they are able to create and trial new treatments for a variety of blood conditions. Professors are currently developing a new vaccine for acute myeloid leukaemia, the first of its kind in the world.

We rely on LIBRA to help fund our research programmes and with its continued support we can find new ways to tackle blood disorders and cancers. Without the long-term support from LIBRA we wouldn't have been able to open our new Cell Therapy Unit which is vital for the development of new and improved treatments for leukaemia and allied blood cancers.
Professor Ghulam Mufti, Head of Haematology, King's College Hospital
LIBRA's support for the Heamatology Department here at King's has been phenominal. It has allowed us to not only do things better, but also has enabled us to have technologies that allow us to research treatments that are being used not only at King's but at other centres also.
Professor Farzin Farzaneh, Head of Molecular Medicine, Kings College Hospital
Life on the LIBRA ward is very friendly. It's a good environment for patients, most of whom will be staying for 2 - 3 weeks at a time for treatment.
Laura Reiff-Zall, Deputy Head of Nursing
We need support from people to raise funds to help the professors save lives. Their research benefits not only patients, but future generations.
Andrew Lodge, LIBRA Chairman
Donate Today